GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Shiller PE Ratio

LOBEF (Lobe Sciences) Shiller PE Ratio : (As of Apr. 14, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lobe Sciences Shiller PE Ratio Historical Data

The historical data trend for Lobe Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Shiller PE Ratio Chart

Lobe Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lobe Sciences Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lobe Sciences's Shiller PE Ratio

For the Biotechnology subindustry, Lobe Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Shiller PE Ratio falls into.


;
;

Lobe Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lobe Sciences's E10 for the quarter that ended in Nov. 2024 is calculated as:

For example, Lobe Sciences's adjusted earnings per share data for the three months ended in Nov. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=0/127.8378*127.8378
=0.000

Current CPI (Nov. 2024) = 127.8378.

Lobe Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 98.367 0.000
201503 -0.022 99.789 -0.028
201506 -0.015 100.500 -0.019
201509 -0.015 100.421 -0.019
201512 -0.127 99.947 -0.162
201603 -0.011 101.054 -0.014
201606 -0.008 102.002 -0.010
201609 -0.015 101.765 -0.019
201612 -0.055 101.449 -0.069
201703 -0.009 102.634 -0.011
201706 -0.016 103.029 -0.020
201709 -0.010 103.345 -0.012
201712 -0.059 103.345 -0.073
201803 -0.013 105.004 -0.016
201806 -0.009 105.557 -0.011
201809 -0.016 105.636 -0.019
201812 -0.142 105.399 -0.172
201903 -0.045 106.979 -0.054
201908 -0.064 108.085 -0.076
201911 -0.045 107.769 -0.053
202002 -0.090 108.559 -0.106
202005 -0.043 107.532 -0.051
202008 -0.227 108.243 -0.268
202011 -0.046 108.796 -0.054
202102 -0.095 109.745 -0.111
202105 0.264 111.404 0.303
202108 -0.230 112.668 -0.261
202111 -0.095 113.932 -0.107
202202 -0.063 115.986 -0.069
202205 -0.039 120.016 -0.042
202208 -0.046 120.569 -0.049
202211 -0.022 121.675 -0.023
202302 -0.007 122.070 -0.007
202305 -0.002 124.045 -0.002
202308 -0.013 125.389 -0.013
202311 -0.007 125.468 -0.007
202402 -0.007 125.468 -0.007
202405 -0.002 127.601 -0.002
202408 -0.015 127.838 -0.015
202411 0.000 127.838 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lobe Sciences  (OTCPK:LOBEF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lobe Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences Business Description

Traded in Other Exchanges
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.